{"id":865952,"date":"2025-07-01T19:52:55","date_gmt":"2025-07-01T23:52:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/"},"modified":"2025-07-01T19:52:55","modified_gmt":"2025-07-01T23:52:55","slug":"investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/","title":{"rendered":"INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEWTOWN, Pa., July  01, 2025  (GLOBE NEWSWIRE) &#8212; <strong>Edelson Lechtzin LLP<\/strong> is investigating potential violations of the federal securities laws involving Hims &amp; Hers Health, Inc. (\u201cHims\u201d) (NYSE: HIMS), resulting from allegations of providing potentially misleading business information to the investing public.<\/p>\n<p>\n        <strong>If you would like to speak with an attorney about the Hims investigation and the potential recovery of your investment losses, please provide your information <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6sbTXv242wv8c95-GDvlp051uRUztEXM2F8N_XA_GI-7d5Hy5d1qH4kZkMynK1OUMpHImdo2MGMH9WPbj4Eb2ujR7TroOlC2Bnm06BcpZt7rRxNs4DtIHVs6iAxXbnxqFy5wqCCvmDD8V0GhCk4j6w==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>HERE<\/strong><br \/>\n        <\/a><br \/>\n        <strong>.<\/strong>\n      <\/p>\n<p>\n        <strong>You can also contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 or via e-mail at <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lzTohKrqCRVqfMXedpPjbU9ADdK8bML6lwUSv-CAfLo07625eqOkj2QDOO3UKUzKTmf3Wf-psrpU77jcYpPx7xfmtN3HjDuLQbNGqYg2mTTZoAPDWKUTBgF-OjkiVZkw\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <strong>elechtzin@edelson-law.com<\/strong><br \/>\n        <\/a><br \/>\n        <strong>. <\/strong>\n      <\/p>\n<p>\n        <strong>THE COMPANY: <\/strong>\n      <\/p>\n<p>Hims is a telehealth and online pharmacy company that offers prescription and over-the-counter medications, mental health services, and personal care products through a direct-to-consumer platform, connecting users with licensed healthcare professionals in the U.S. and the U.K.<\/p>\n<p>\n        <strong>THE ALLEGED WRONGDOING<\/strong><br \/>\n        <strong>: <\/strong>\n      <\/p>\n<p>On April 29, 2025, multinational pharmaceutical company Novo Nordisk announced that it would sell its weight loss drug Wegovy through Hims\u2019 telehealth platform. On June 23, 2025, Novo Nordisk terminated its partnership with Hims, citing concerns about Hims\u2019 compliance with laws governing the sale and marketing of compounded drugs.<\/p>\n<p>On this news, Hims\u2019 stock price fell $22.24 per share, or 34.63%, to close at $41.98 per share on June 23, 2025.<\/p>\n<p>\n        <strong>ABOUT EDELSON LECHTZIN LLP: <\/strong>Edelson Lechtzin LLP is a national class action law firm with offices in Philadelphia and San Francisco. In addition to cases involving securities and investment fraud, our lawyers focus on class action cases alleging violations of federal antitrust laws, employee benefit plans under ERISA, wage theft, data security breaches, and consumer fraud.<\/p>\n<p>\n        <u>For more information, please contact:<\/u>\n      <\/p>\n<p>Marc H. Edelson, Esq.<br \/>Eric Lechtzin, Esq.<br \/>EDELSON LECHTZIN LLP<br \/>411 S. State Street, Suite N-300<br \/>Newtown, PA 18940<br \/>Phone: 844-696-7492 or 215-867-2399 ext. 1 <br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XaYfRV89oWCCM3aRl0bAObTvB5U4hX9LxDmXFAS-DyXg7He4r0n-_FfjdKl0Mivwb4DOM9xgonvNPqBm6Qb0TCm3cTWihPKT5hxEf-nDQ7JuJVf_QxdyrCjbEfmrzsNB\" rel=\"nofollow\" target=\"_blank\">medelson@edelson-law.com<\/a><br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lzTohKrqCRVqfMXedpPjbU9ADdK8bML6lwUSv-CAfLr2Li2bBiIv7-XG2JyZ2D72v5TTvx4gsVqDNclNORlc4qV5gTS4RXrDLdmpnJKVOoddu1yoTe_hWyqK61fOWK5v\" rel=\"nofollow\" target=\"_blank\">elechtzin@edelson-law.com<\/a>\u00a0\u00a0 <br \/>Web: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=W4_AzmDTooXg1sbJB6btyGJegxKln9QIqHIWtU_m4DHDYjhLjukPZ6gbyH-Anphzj7xGVQzoxccekPMLUwzEMxuoL0_j-_M5_ai1ZMgepXg=\" rel=\"nofollow\" target=\"_blank\">www.edelson-law.com<\/a><\/p>\n<p>This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODA4NyM3MDI4NzQ5IzIyNTE3NTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YWY4NDNkYjctNTYxMi00MmQxLWIxMzMtMzI5NzkyYzVkZDVlLTEyNjMzMDQtMjAyNS0wNy0wMS1lbg==\/tiny\/Edelson-Lechtzin-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEWTOWN, Pa., July 01, 2025 (GLOBE NEWSWIRE) &#8212; Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Hims &amp; Hers Health, Inc. (\u201cHims\u201d) (NYSE: HIMS), resulting from allegations of providing potentially misleading business information to the investing public. If you would like to speak with an attorney about the Hims investigation and the potential recovery of your investment losses, please provide your information HERE . You can also contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 or via e-mail at elechtzin@edelson-law.com . THE COMPANY: Hims is a telehealth and online pharmacy company that offers prescription and over-the-counter medications, mental health services, and personal care products through a direct-to-consumer platform, connecting users with licensed &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-865952","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWTOWN, Pa., July 01, 2025 (GLOBE NEWSWIRE) &#8212; Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Hims &amp; Hers Health, Inc. (\u201cHims\u201d) (NYSE: HIMS), resulting from allegations of providing potentially misleading business information to the investing public. If you would like to speak with an attorney about the Hims investigation and the potential recovery of your investment losses, please provide your information HERE . You can also contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 or via e-mail at elechtzin@edelson-law.com . THE COMPANY: Hims is a telehealth and online pharmacy company that offers prescription and over-the-counter medications, mental health services, and personal care products through a direct-to-consumer platform, connecting users with licensed &hellip; Continue reading &quot;INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-01T23:52:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODA4NyM3MDI4NzQ5IzIyNTE3NTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm\",\"datePublished\":\"2025-07-01T23:52:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/\"},\"wordCount\":389,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODA4NyM3MDI4NzQ5IzIyNTE3NTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/\",\"name\":\"INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODA4NyM3MDI4NzQ5IzIyNTE3NTE=\",\"datePublished\":\"2025-07-01T23:52:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODA4NyM3MDI4NzQ5IzIyNTE3NTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ4ODA4NyM3MDI4NzQ5IzIyNTE3NTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/","og_locale":"en_US","og_type":"article","og_title":"INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Market Newsdesk","og_description":"NEWTOWN, Pa., July 01, 2025 (GLOBE NEWSWIRE) &#8212; Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Hims &amp; Hers Health, Inc. (\u201cHims\u201d) (NYSE: HIMS), resulting from allegations of providing potentially misleading business information to the investing public. If you would like to speak with an attorney about the Hims investigation and the potential recovery of your investment losses, please provide your information HERE . You can also contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 or via e-mail at elechtzin@edelson-law.com . THE COMPANY: Hims is a telehealth and online pharmacy company that offers prescription and over-the-counter medications, mental health services, and personal care products through a direct-to-consumer platform, connecting users with licensed &hellip; Continue reading \"INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-01T23:52:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODA4NyM3MDI4NzQ5IzIyNTE3NTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm","datePublished":"2025-07-01T23:52:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/"},"wordCount":389,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODA4NyM3MDI4NzQ5IzIyNTE3NTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/","name":"INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODA4NyM3MDI4NzQ5IzIyNTE3NTE=","datePublished":"2025-07-01T23:52:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODA4NyM3MDI4NzQ5IzIyNTE3NTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ4ODA4NyM3MDI4NzQ5IzIyNTE3NTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investigation-alert-edelson-lechtzin-llp-announces-investigation-of-hims-hers-health-inc-nyse-hims-and-encourages-investors-with-substantial-losses-or-witnesses-with-relevant-information-t\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Hims &amp; Hers Health, Inc. (NYSE: HIMS) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/865952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=865952"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/865952\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=865952"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=865952"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=865952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}